0001140361-15-021752.txt : 20150526 0001140361-15-021752.hdr.sgml : 20150525 20150526182805 ACCESSION NUMBER: 0001140361-15-021752 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150521 FILED AS OF DATE: 20150526 DATE AS OF CHANGE: 20150526 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REPLIGEN CORP CENTRAL INDEX KEY: 0000730272 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 042729386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7814499560 MAIL ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DAWES KAREN A CENTRAL INDEX KEY: 0001261506 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14656 FILM NUMBER: 15890590 MAIL ADDRESS: STREET 1: 579 BELLEVUE AVE CITY: NEWPORT STATE: RI ZIP: 02840 4 1 doc1.xml FORM 4 X0306 4 2015-05-21 0 0000730272 REPLIGEN CORP RGEN 0001261506 DAWES KAREN A C/O REPLIGEN CORPORATION 41 SEYON STREET, BLDG 1, STE 100 WALTHAM MA 02453 1 0 0 0 Common Stock 2015-05-21 4 A 0 1498 0 A 39241 D Stock Option (Right to Buy) 41.19 2015-05-21 4 A 0 2929 0 A 2016-05-21 2025-05-21 Common Stock 2929 2929 D Ms. Dawes was awarded 1,498 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The Restricted Stock Units vest on May 21, 2016. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Award vests in full one year from grant date on May 21, 2016. /s/ Jeffrey P. Leduc (Attorney in Fact) 2015-05-26